XML 33 R23.htm IDEA: XBRL DOCUMENT v3.21.2
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Accounting Policies [Abstract]        
Research and Development Expense $ 112,610 $ 95,460 $ 323,052 $ 373,769
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount     655,700,312 654,492,154
Depreciation $ 5,465 $ 5,015 $ 16,395 $ 15,045